Catalyst Wire Dossier Catalyst Wire Dossier

Uterine Blood Mesenchymal Stem Cells Injection

· Ruijin Hospital
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Uterine Blood Mesenchymal Stem Cells Injection, covering 2024-12-27 to 2024-12-27. Get the full timeline:

Most recent: Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by Viruses [Phase 1]

See pricing